Search
for
Sort by
Research 30 of 1000+
- Alopecia due to high androgen index contraceptives
- Polycystic Ovary Syndrome (PCOS) and Other Androgen Excess–Related Conditions: Can Changes in Dietary Intake Make a Difference?
- Controversies in Polycystic Ovary Syndrome
- Hormonal contraceptives: pharmacology tailored to women's health
- Nutrition and acne
- New onset of alopecia in a young woman with end-stage renal disease
- PCOS and Obesity: Contraception Challenges
- Prostate-Sparing Effects in Primates of the Potent Androgen 7α-Methyl-19-Nortestosterone: A Potential Alternative to Testosterone for Androgen Replacement and Male Contraception1
- Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
- The Role of Oral Contraceptives in the Treatment of Hyperandrogenic Disorders
- Ovarian and Adrenal Androgens and Their Link to High Human Chorionic Gonadotropin Levels: A Prospective Controlled Study
- Targets to treat androgen excess in polycystic ovary syndrome
- Androgen excess: a hallmark of polycystic ovary syndrome
- Androgens and Antiandrogens
- Cardiovascular risk factors and events in women with androgen excess
- Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
- Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study
- Pharmacology of anabolic steroids
- A Review of Androgen‐Progestin Regimens for Male Contraception
- Endocrine disorders and hormonal therapy for adolescent acne
- Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities
- PCOS: update and diagnostic approach
- Effective treatment of skin and metabolic manifestations of hyperandrogenism: a comprehensive improvement of quality of life
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
- Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
- Polycystic Ovarian Morphology is Associated with Hyperandrogenemia and Insulin Resistance in Women with Polycystic Ovary Syndrome (PCOS)
- Pharmacotherapy of polycystic ovary syndrome - an update
- Ovarian Hypertension: Polycystic Ovary Syndrome
- 105 Spironolactone May be a Cause of Hormonally Associated Vestibulodynia and Female Genital Arousal Disorder
- Managing the PCOS-Related Symptoms of Hirsutism, Acne, and Hair Loss